跳到正文
原文
Endpoints News 生物医药· Max Gelman·· 5 天前AI 评分55

FDA拒绝Summit和Akeso的肺癌治疗药物申请

FDA rejects Summit, Akeso's ivonescimab in narrow lung cancer setting

AI 导读

FDA拒绝Summit和Akeso的肺癌治疗药物ivonescimab的申请,分析师认为这不会影响该药物的市场前景。

正文

The FDA re­ject­ed a new can­cer treat­ment from Sum­mit Ther­a­peu­tics and Ake­so in a de­ci­sion that an­a­lysts large­ly ex­pect­ed, but ul­ti­mate­ly shouldn’t dim the prospects …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news